TRX 712
Alternative Names: TRX-712Latest Information Update: 30 Mar 2025
At a glance
- Originator TRx Biosciences
- Class Anti-inflammatories; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Chronic obstructive pulmonary disease
Most Recent Events
- 17 Feb 2025 Early research in Chronic obstructive pulmonary disease in United Kingdom (PO) (TRx Biosciences pipeline; February 2025)